Drug Database
Back to search

Czechia· CZ-0268597

ADZYNMA

A apadamtase alfa und cinaxadamtase alfa product containing radamts13, registered in Czechia by Takeda Manufacturing Austria AG, Vídeň. The same ATC class is registered in 10 of our 19 countries.

ATC B01AD13

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedADZYNMAATCB01AD13REGISTER NO.CZ-0268597PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about radamts13Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Apadamtase alfa und cinaxadamtase alfa is registered in 10 of 19 countries.

Countries holding a registration under ATC B01AD13 (apadamtase alfa und cinaxadamtase alfa), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search apadamtase alfa und cinaxadamtase alfa products by name

Apadamtase alfa und cinaxadamtase alfa · ATC B01AD13

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
RADAMTS13
Manufacturer
Takeda Manufacturing Austria AG, Vídeň
Country
Czechia (CZ)
ATC code
B01AD13
ATC class
Apadamtase alfa und Cinaxadamtase alfa
Defined daily dose
200 E, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under B01AD13

Apadamtase alfa und cinaxadamtase alfa, as other registers publish it.

All apadamtase alfa und cinaxadamtase alfa products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/20edddfe-6409-41d0-924f-e67402e79e8b
GET /v1/drugs/20edddfe-6409-41d0-924f-e67402e79e8b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ PSO LQF",
  "source": "sukl",
  "strength": "1500IU",
  "pack_size": "1+5ML+BAXJECT+STŘ",
  "substance": "RADAMTS13",
  "cz_kod_sukl": "0268597",
  "product_type": "BT",
  "substance_codes": "3920",
  "registration_state": "R",
  "registration_number": "EU/1/24/1837/002"
}
API referenceMCP serverPlans

See everything about apadamtase alfa und cinaxadamtase alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console